New study details enzyme that allows coronavirus to resist antiviral medications

A new study details the structure of a critical enzyme present in SARS-CoV-2, the coronavirus that causes COVID-19. This enzyme removes nucleoside antiviral medications from the virus's RNA, rendering many treatments ineffective. Scientists could use data uncovered in the new study to find ways to inhibit the enzyme, possibly leading to more effective treatments.

from Top Health News -- ScienceDaily https://ift.tt/2VmqlPB